Xeris Pharmaceuticals(DE:2B30)
€13.96+0.09 (+0.61%)
DE:2B30
Xeris Pharmaceuticals earnings date
€13.96
At close:+0.09 (+0.61%)
Xeris Pharmaceuticals (2B30) Q1 2022 Earnings Report
0 Followers
DE:2B30 Q1 2022 EPS Results
- Actual EPS
- -EUR 0.22
- Consensus EPS
- -EUR 0.22
- Beat/Miss
- Missed by -EUR 0.01
- One Year Ago EPS
- -EUR 0.27
DE:2B30 Q1 2022 Revenue Results
- Actual Revenue
- EUR 19.76M
- Expected Revenue
- EUR 20.94M
- Beat/Miss
- Missed by -EUR 1.18M
- YoY Revenue Growth
- ―
Earnings Announcement Details
- Quarter
- Q1 2022
- Date
- 05/11/2022
- Time
- Before Open
- Conference Call
- Wednesday, May 11, 2022
DE:2B30 Upcoming Earnings
Xeris Pharmaceuticals's next earnings date is estimated for March 10, 2027, based on past reporting schedules.
Q1 2022 Earnings Call Audio
No earnings call audio is available for this earnings event.
Q1 2022 Earnings Slide Deck
No slide deck is available for this earnings event.
Q1 2022 Earnings Call Summary
No earnings call summary is available for this earnings event.
DE:2B30 Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Mar 10, 2027 | 2026 (Q4) | 0.06- | 0.05 | ― | ― |
| Nov 05, 2026 | 2026 (Q3) | 0.030.05 | 0 | ― | |
| Aug 06, 2026 | 2026 (Q2) | 0.01-0.16 | -0.01 | -1700.00% (-0.15) | |
| May 07, 2026 | 2026 (Q1) | -0.000.01 | -0.05 | 116.67% (+0.06) | |
| Mar 02, 2026 | 2025 (Q4) | 0.020.05 | -0.03 | 300.00% (+0.08) | |
| Nov 06, 2025 | 2025 (Q3) | 0.010.00 | -0.1 | 100.00% (+0.10) | |
| Aug 07, 2025 | 2025 (Q2) | -0.03-0.01 | -0.09 | 90.00% (+0.08) | |
| May 08, 2025 | 2025 (Q1) | -0.04-0.05 | -0.13 | 57.14% (+0.07) | |
| Mar 06, 2025 | 2024 (Q4) | -0.05-0.03 | -0.09 | 70.00% (+0.06) | |
| Nov 08, 2024 | 2024 (Q3) | -0.08-0.10 | -0.08 | -22.22% (-0.02) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed
